Integra LifeSciences Holdings (IART) — Analysis Summary
Integra LifeSciences Holdings (IART) has a market cap of $1.25B with year-over-year revenue growth of +1.5%. Net margin stands at -31.6%. The stock trades at a P/E ratio of -2.5.
Key Takeaways
- Revenue changed +1.5% year-over-year
- Net margin of -31.6%
- P/E ratio of -2.5
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, IART posted revenue growth of +1.5% and trades at a P/E of -2.5.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.